ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1832

Proteomic and Transcriptomic Profiling of Cells in Ankylosing Spondylitis Patients Identifies a Novel, Synovial-Resident CD8+ T Cell

Zoya Qaiyum1, Eric Gracey2, Yuchen Yao2 and Robert D Inman3, 1Department of Immunology, University of Toronto, Toronto, ON, Canada, 2Krembil Research Institute, Toronto Western Hospital, Toronto, ON, Canada, 3Toronto Western Hospital, University of Toronto, Spondylitis Clinic, Toronto, ON, Canada

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: CyTOF, integrins and synovial cells, RNA, synovial fluid

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: 4M088 ACR Abstract: Spondyloarthritis Incl PsA–Basic Science (1828–1833)

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Current data suggests that immune events in the gut may impact on joint inflammation in ankylosing spondylitis (AS) but what directs cells in the gut-joint axis is undefined. For this reason, we examined the expression of trafficking molecules on immune cells using Cytometry by Time-of-flight (CyTOF), and the expression of differentially regulated genes using bulk RNA-sequencing (RNA-seq). Our objectives are to utilize proteomic and transcriptomic analysis to 1) assess differential expression patterns of trafficking molecules between patients and controls, 2) generate joint-specific cellular signatures, and 3) obtain genetic profiles of noteworthy cell subpopulations.

Methods: Male subjects under 40 years of age fulfilling the mNY criteria were recruited. The following cells were surface stained using a 36-marker antibody panel: (i) Peripheral blood mononuclear cells (PBMC) from AS patients, and healthy controls; (ii) Synovial fluid mononuclear cells (SFMC) from AS and rheumatoid arthritis (RA) patients. After acquiring on CyTOF2, data were analysed using SPADE, viSNE and FlowJo programs for data visualization and statistical analysis. Additionally, bulk RNA-seq was performed on CD8+ T cell subpopulations from the synovial fluid. Pathway analysis of differentially expressed genes was conducted using the ClueGo application from the Cytoscape program.

Results: Mature CD8+ T cells were increased in frequency in AS SFMC, with significant changes in their phenotype: β7+, CD103+, CD29+ and CD49a+ integrin expression was increased in CD8+CD45RO+ cells in AS SFMC vs paired AS PBMC (mean 7.51% vs 0.87%, p=0.0035). A similar comparison in RA SFMC vs paired RA PBMC revealed less dramatic changes (mean 3.11% vs 0.33%, p=0.0056). RNA-seq data analysis of CD103+CD49a+ cells in AS SFMC revealed elevated GZMA, GZMB, PRF1 and IL-10 cytokines, in addition to a cytotoxicity regulation profile. Signaling molecules, such as TNFAIP3 and TIAF1, and transcription factors, such as RUNX1 and IRF4, were elevated as well.

Conclusion: We identified a novel integrin-expressing mature CD8+ T cell subset (CD49a+CD103+β7+CD29+) that appears to be more prevalent in AS SF than RA SF. These cells possess a dual proinflammatory and regulatory profile, suggesting these roles may be microenvironment-dependent. Further experiments are ongoing to provide evidence of gut-joint trafficking capabilities using murine models. Examinations of patient gut and synovial tissue biopsies, as well as murine gut and joint tissue are essential to determine the arthritogenic potential of these cells. A global analysis encompassing transcriptional and proteomic changes is mandated to provide crucial insights into the inflammatory relationship between the gut and joint, which in turn would be important to design innovative immunotherapy for AS.


Disclosure: Z. Qaiyum, None; E. Gracey, None; Y. Yao, None; R. D. Inman, None.

To cite this abstract in AMA style:

Qaiyum Z, Gracey E, Yao Y, Inman RD. Proteomic and Transcriptomic Profiling of Cells in Ankylosing Spondylitis Patients Identifies a Novel, Synovial-Resident CD8+ T Cell [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/proteomic-and-transcriptomic-profiling-of-cells-in-ankylosing-spondylitis-patients-identifies-a-novel-synovial-resident-cd8-t-cell/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/proteomic-and-transcriptomic-profiling-of-cells-in-ankylosing-spondylitis-patients-identifies-a-novel-synovial-resident-cd8-t-cell/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology